306 related articles for article (PubMed ID: 6134240)
21. [Role of antiaggregant platelet drugs in thromboembolism].
Tullio D
G Ital Cardiol; 1981; 11(8):1131-40. PubMed ID: 6173281
[No Abstract] [Full Text] [Related]
22. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
23. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
[No Abstract] [Full Text] [Related]
24. [Secondary prevention following myocardial infarct].
Follath F
Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1177-80. PubMed ID: 2877482
[No Abstract] [Full Text] [Related]
25. Myocardial infarction--secondary prevention.
Hjalmarson A
Acta Med Scand Suppl; 1986; 712():35-9. PubMed ID: 2880462
[No Abstract] [Full Text] [Related]
26. [Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Loew D; Breddin K; Uberla K
MMW Munch Med Wochenschr; 1982 Jan; 124(1):46-56. PubMed ID: 6120454
[No Abstract] [Full Text] [Related]
27. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
28. [Secondary prevention of ischemic cardiopathy].
Caruzzo E; Caruzzo C
Cardiologia; 1995 May; 40(5):347-53. PubMed ID: 8529246
[No Abstract] [Full Text] [Related]
29. [Drug therapy as secondary prevention following myocardial infarction].
Cottier C
Praxis (Bern 1994); 1996 Apr; 85(17):545-7. PubMed ID: 8668892
[No Abstract] [Full Text] [Related]
30. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
31. [Correction of thrombophilia].
Caruzzo C; Marcolongo M; Arpino E; Di Summa M
Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
[No Abstract] [Full Text] [Related]
32. Medical prophylaxis for the post myocardial infarct patient.
Cohen LS
Cardiol Clin; 1988 Feb; 6(1):173-8. PubMed ID: 2901909
[TBL] [Abstract][Full Text] [Related]
33. [The platelet inhibitor problem].
Straub PW
Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
[TBL] [Abstract][Full Text] [Related]
34. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Bousser MG
J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
[TBL] [Abstract][Full Text] [Related]
35. [Secondary prevention following myocardial infarction--results of long-term studies].
Berndt H
Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
[No Abstract] [Full Text] [Related]
36. Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
Dalen JE; Goldberg RJ; Gore JM; Struckus J
Chest; 1984 Aug; 86(2):257-62. PubMed ID: 6146500
[No Abstract] [Full Text] [Related]
37. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of myocardial infarction.
de Bono DP
Scott Med J; 1981 Jul; 26(3):194-6. PubMed ID: 6115470
[No Abstract] [Full Text] [Related]
39. [New aspects in the prophylaxis of myocardial reinfarction (author's transl)].
Hitzenberger G
Aktuelle Gerontol; 1982 Jan; 12(1):7-11. PubMed ID: 6121504
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic management of the myocardial infarction patient after discharge from the hospital.
Rosman HS; Goldstein S
Cardiovasc Clin; 1984; 14(3):127-37. PubMed ID: 6144387
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
